Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
155b Commerce Drive , Hauppauge, NY, 11788, US
Renejix is the leading end to end CDMO accelerator for small molecule oral dosage forms at a competitive price. We have produced over 200 FDFs, 5+ billion dosages annually, and have a staff of ~500 employees. Take your molecules from concept to commercialization in record time by cutting 20 weeks off early and late phase timelines!
Approved as the first targeted medicine in the EU in over a decade for chronic spontaneous urticaria.
By: Charlie Sternberg
Veeva to deliver next-gen customer engagement with agentic AI for Roche.
Plans an expansion of its flagship biologics manufacturing facility in Frederick and construction of a new facility in Gaithersburg.
Codis launches as a global CDMO specializing in spray drying, amorphous solid dispersions, and particle engineering, uniting Particle Dynamics and EUROAPI’s former Haverhill facility under one brand.
Released By Codis
The transaction is expected to close in the first quarter of 2026.
Lee will head AdvanCell’s U.S. expansion, accelerating clinical, manufacturing, and partnership activities.
Carlos Martin joins the company with over 20 years of leadership experience.
By: Rachel Klemovitch
Cuillerot brings extensive pharmaceutical and biotech experience, with a proven track record in leading successful clinical development programs and regulatory strategy.
Lessons Learned and Best Practices from a CDMO Perspective
Released By Upperton
Collaboration combines ATCC’s portfolio of authenticated cell lines with acCELLerate’s expertise in cryopreservation and its capabilities for large scale cell banking.
Dr. Dean will lead all preclinical research and development activities that support the progression of Odyssey’s drug candidates from discovery to clinical trials.
Kuvalanka brings over 20 years of experience in biopharmaceutical leadership, including finance, business development, and corporate strategy.
Reddy offers more than a decade of experience in corporate development and strategy within the life sciences sector.
Boura has been with the company since 2021 and was named deputy CMO in February 2025.
Will leverage AJICAP antibody-drug conjugate development and manufacturing technology as part of its CDMO business.
By: Kristin Brooks
Enter the destination URL
Or link to existing content
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !
